Polypeptide-based nanogels co-encapsulating a synergistic combination of Doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models

類似資料

• Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition
  著者:: Raja, Srikumar M., 等
  出版事項: (2016)
• Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation
  著者:: Soni, Kruti S., 等
  出版事項: (2015)
• Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer
  著者:: Ortega-Cava, Cesar F., 等
  出版事項: (2011)
• A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells
  著者:: Bailey, Tameka A., 等
  出版事項: (2014)
• Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer
  著者:: Soni, Kruti S., 等
  出版事項: (2017)